These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23686358)

  • 21. Implementing type I & type II error spending for two-sided group sequential designs.
    Rudser KD; Emerson SS
    Contemp Clin Trials; 2008 May; 29(3):351-8. PubMed ID: 17933592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Planning and analyzing adaptive group sequential survival trials.
    Wassmer G
    Biom J; 2006 Aug; 48(4):714-29. PubMed ID: 16972724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adaptive group sequential test for clinical trials with changing patient population.
    Feng H; Shao J; Chow SC
    J Biopharm Stat; 2007; 17(6):1227-38. PubMed ID: 18027228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypothesis testing for two-stage designs with over or under enrollment.
    Zeng D; Gao F; Hu K; Jia C; Ibrahim JG
    Stat Med; 2015 Jul; 34(16):2417-26. PubMed ID: 25809924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Confidence intervals for ratios of AUCs in the case of serial sampling: a comparison of seven methods.
    Jaki T; Wolfsegger MJ; Ploner M
    Pharm Stat; 2009; 8(1):12-24. PubMed ID: 18407562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sample size re-estimation for survival data in clinical trials with an adaptive design.
    Togo K; Iwasaki M
    Pharm Stat; 2011; 10(4):325-31. PubMed ID: 22328325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exact likelihood ratio and score confidence intervals for the binomial proportion.
    Somerville MC; Brown RS
    Pharm Stat; 2013; 12(3):120-8. PubMed ID: 23471686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Point and interval estimation of primary and secondary parameters in a two-stage adaptive clinical trial.
    Liu A; Wu C; Yu KF
    J Biopharm Stat; 2008; 18(2):211-26. PubMed ID: 18327717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of adaptive designs: efficiency evaluation.
    Menon S; Chang M
    J Biopharm Stat; 2012; 22(4):641-61. PubMed ID: 22651106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of group sequential designs in clinical trials on the basis of detectable treatment differences.
    Schäfer H; Müller HH
    Stat Med; 2004 May; 23(9):1413-24. PubMed ID: 15116350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adaptive designs for confirmatory clinical trials.
    Bretz F; Koenig F; Brannath W; Glimm E; Posch M
    Stat Med; 2009 Apr; 28(8):1181-217. PubMed ID: 19206095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adaptive design in clinical research: issues, opportunities, and recommendations.
    Chang M; Chow SC; Pong A
    J Biopharm Stat; 2006 May; 16(3):299-309; discussion 311-2. PubMed ID: 16724486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Data-driven analysis strategies for proportion studies in adaptive group sequential test designs.
    Wassmer G
    J Biopharm Stat; 2003 Nov; 13(4):585-603. PubMed ID: 14584710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A general statistical principle for changing a design any time during the course of a trial.
    Müller HH; Schäfer H
    Stat Med; 2004 Aug; 23(16):2497-508. PubMed ID: 15287080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On sample size and inference for two-stage adaptive designs.
    Liu Q; Chi GY
    Biometrics; 2001 Mar; 57(1):172-7. PubMed ID: 11252594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving the efficiency of estimation in randomized trials of adaptive treatment strategies.
    Lavori PW; Dawson R
    Clin Trials; 2007; 4(4):297-308. PubMed ID: 17848491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adaptive trial design: a general methodology for censored time to event data.
    Jahn-Eimermacher A; Ingel K
    Contemp Clin Trials; 2009 Mar; 30(2):171-7. PubMed ID: 19130902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adaptive designs at European Organisation for Research and Treatment of Cancer (EORTC) with a focus on adaptive sample size re-estimation based on interim-effect size.
    Mauer M; Collette L; Bogaerts J;
    Eur J Cancer; 2012 Jun; 48(9):1386-91. PubMed ID: 22281098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interval estimation of the mean response in a log-regression model.
    Wu J; Wong AC; Wei W
    Stat Med; 2006 Jun; 25(12):2125-35. PubMed ID: 16220472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Group sequential and adaptive designs: a novel, promising tool for nursing research.
    Baldi I; Gouchon SM; Di Giulio P; Buja A; Gregori D
    J Adv Nurs; 2011 Aug; 67(8):1824-33. PubMed ID: 21517937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.